Users Stopping Anti-Obesity Medications Regain Weight Four Times Faster Compared to People Using Diet and Exercise

Fresh analysis indicates that individuals who discontinue popular slimming jabs like semaglutide or tirzepatide tend to recover shed pounds far faster than those who end conventional lifestyle plans.

Research printed in a prominent health publication points out that while overweight individuals frequently drop a large proportion of their body weight while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month once they quit.

"Users using these treatments must be informed of the danger of quick rebound weight gain when the medication ends," cautioned researcher Dr. Susan Jebb.

This pace of regain implies a reversion to starting weight in about one and a half years.

Analyzing Approaches

The analysis, which reviewed dozens of studies involving over 9,000 of participants, compared the effects of the injectable medications with other pills.

The team emphasize that people who shed pounds through lifestyle changes alone typically have a slower weight regain—approximately 0.1 kg a month—after stopping.

Explaining the Fast Regain

Experts suggest the mode of action of the jabs is key to understanding the accelerated weight return.

The injections copy a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.

"Artificially providing the hormone concentrations several times higher than normal may cause the body to generate a reduced amount of its own natural GLP-1, and could reduce sensitivity to its effects," said Dr. Adam Collins, a dietetics specialist.

"Stopping of this GLP-1 'fix' means appetite is uncontrolled, making binge eating far more likely."

A Lifelong Disease?

Health authorities advise the jabs for individuals with obesity-related medical conditions, alongside prescribed lifestyle changes.

A number of clinicians argue that, considering the high risk of weight regain, the treatment should be considered long-term.

This perspective is echoed by drug manufacturers, who note that the results "underscore the chronic nature of excess weight," comparing it to managing diseases like hypertension.

Patient Experiences

Users who have stopped the medication explain a intense resurgence of hunger.

"It felt as if something that goes on and I was suddenly extremely hungry," recalled one woman.

This difficulty is compounded if patients have not developed lasting lifestyle or habit changes during therapy.

Growing Interest

Recent estimates show that millions of people in the UK have tried these injections in the last 12 months, with demand remaining high.

• Use is higher among women compared to males.
• The 40s and 50s demographic shows the highest usage rates.
• A large proportion access the medications through private prescriptions rather than public health services.

In conclusion, experts caution that while these medications are effective agents for weight loss, they are not a standalone cure and maintained weight loss hinges on integrated lifestyle management.